Compare LMRI & SLRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LMRI | SLRC |
|---|---|---|
| Founded | 2018 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 753.7M | 803.0M |
| IPO Year | N/A | 2007 |
| Metric | LMRI | SLRC |
|---|---|---|
| Price | $9.37 | $15.60 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 7 |
| Target Price | ★ $20.75 | $15.14 |
| AVG Volume (30 Days) | ★ 831.9K | 291.7K |
| Earning Date | 05-12-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 10.52% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.70 |
| Revenue | N/A | N/A |
| Revenue This Year | $6.35 | $1.09 |
| Revenue Next Year | $5.61 | N/A |
| P/E Ratio | ★ N/A | $9.22 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.23 | $13.78 |
| 52 Week High | $19.45 | $17.20 |
| Indicator | LMRI | SLRC |
|---|---|---|
| Relative Strength Index (RSI) | 42.69 | 56.04 |
| Support Level | $8.82 | $14.88 |
| Resistance Level | $10.35 | $16.61 |
| Average True Range (ATR) | 0.62 | 0.36 |
| MACD | 0.17 | -0.03 |
| Stochastic Oscillator | 36.60 | 49.68 |
Lumexa Imaging Holdings Inc is a provider of diagnostic imaging services. The company offers a broad range of imaging modalities including MRIs, CT scans, PET scans, X-rays, ultrasounds, and mammography. Its products and operations are managed and reported in two operating segments: Outpatient Imaging Centers (Outpatient) and Professional Services (Professional). The professional services segment generates revenue from interpreting imaging studies conducted by other parties, mainly hospital imaging departments. The majority of revenue is generated from the Outpatient segment, which generates revenue by performing imaging studies and providing radiologists' interpretations of those studies.
SLR Investment Corp is a closed-end externally managed, non-diversified management investment company that has elected to be treated as a business development company. It provides U.S. middle market businesses and intermediaries with bespoke debt financing solutions to fund working capital, acquisition, refinancing and growth capital requirements. The company's investment objective is to generate both current income and capital appreciation through debt and equity investments. The company invests principally in leveraged middle-market companies in the form of senior secured loans, financing leases, and to a lesser extent, unsecured loans and equity securities.